STOCK TITAN

Vanguard disaggregates holdings after realignment; Nuvalent (NUVL) ownership listed as 0

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amendment to Schedule 13G reporting zero beneficial ownership of Nuvalent Inc. common stock. The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538 (January 12, 1998). The Schedule 13G/A shows 0 shares and 0% ownership and is signed by Ashley Grim on 03/27/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings after an internal realignment and reports no beneficial ownership.

The amendment states an internal realignment on January 12, 2026 and reliance on SEC Release No. 34-39538 (January 12, 1998), which permits separate reporting by subsidiaries. The filing lists 0 shares and 0% ownership of Nuvalent Inc. common stock.

Implications depend on separate filings by Vanguard subsidiaries; subsequent Schedule 13G/A or Form 13F entries from the named affiliates could show holdings. Timing for any affiliate disclosures is not provided in the excerpt.

This is an administrative ownership disclosure driven by internal reorganization, not a trading event.

The amendment explains that subsidiaries which "formerly had, or were deemed to have, beneficial ownership" will now report separately, and that Vanguard "no longer has, or is deemed to have, beneficial ownership" of those subsidiary-held securities under the cited SEC release. The Schedule explicitly records Amount beneficially owned: 0 and Percent of class: 0%.

From a compliance view, watch for follow-up filings by Vanguard affiliates to locate any previously aggregated holdings; the amendment itself does not change Nuvalent's shareholder registry directly.






670703107

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

What does The Vanguard Group report for NUVL ownership?

The Vanguard Group reports 0 shares and 0% beneficial ownership of Nuvalent Inc. common stock. The Schedule 13G/A amendment explicitly lists Amount beneficially owned as 0 and Percent of class as 0.

Why did Vanguard file this Schedule 13G/A amendment?

Vanguard filed the amendment because of an internal realignment on January 12, 2026. The filing states subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538 (January 12, 1998), causing disaggregated reporting.

Does this filing indicate Vanguard sold Nuvalent shares?

No. The filing attributes the change to an internal realignment and disaggregation under the cited SEC release. It states Vanguard "no longer has, or is deemed to have, beneficial ownership" of subsidiary-held securities rather than describing sales or transactions.

When was the Schedule 13G/A amendment signed and by whom?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with a signature date of 03/27/2026. The filing includes Ashley Grim's name and title as the authorized signer.
Nuvalent, Inc.

NASDAQ:NUVL

View NUVL Stock Overview

NUVL Rankings

NUVL Latest News

NUVL Latest SEC Filings

NUVL Stock Data

7.71B
69.51M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE